Home
About Us
About The CRI
The CRI Team
Our Global Impact
Data & Tools
Overview
Corporate PD & AS
Aggregate PD & AS
Corporate Vulnerability Index
CRI Systemically Important Financial Institution
Calculator
Data Download
Methodology
Technical Documents
White Papers
Conceptual And Scientific Foundation
Insights
Weekly Credit Brief
Credit Brief on SMEs
Special Report
Semi-Annual Credit Summary
Global Credit Review
China A Share Credit Report
Opportunities
Career
News
FAQ
English
简体中文
Sign In
Soaring leverage and upswing in debt-fueled M&A casts shadow over US pharmaceuticals’ credit outlook
2021-08-24 ~ 2021-08-30
Published on: 2021-08-30
<p>This browser does not support PDFs. Please download the PDF to view it:</p>
Download PDF
Privacy Notice
This site uses cookies. By clicking accept or continuing to use this site, you agree to our use of cookies. For more details about cookies and how to manage them, please see our
Privacy Notice
Accept